• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

浆细胞性尿路上皮癌:一种需要积极管理和在经尿道切除术中仔细区分的罕见变异型。

Plasmacytoid Urothelial Carcinoma: An Unusual Variant That Warrants Aggressive Management and Critical Distinction on Transurethral Resections.

机构信息

From Kasturba Medical College, Manipal Academy of Higher Education (MAHE), Mangalore, Karnataka, India (Ms Sood); and the Departments of Pathology and Surgery (Urology), University of Chicago Medical Center, Chicago, Illinois (Dr Paner). At the time of acceptance, Ms Sood was currently a rotating medical student in the Department of Pathology, University of Chicago Medical Center.

出版信息

Arch Pathol Lab Med. 2019 Dec;143(12):1562-1567. doi: 10.5858/arpa.2018-0139-RS. Epub 2019 Mar 13.

DOI:10.5858/arpa.2018-0139-RS
PMID:30865491
Abstract

Plasmacytoid urothelial carcinoma (PUC) is a variant of infiltrating urothelial carcinoma that is characterized by tumor cells that have striking morphologic resemblance to and immunohistochemical overlap with plasma cells, and that harbors mutation. Plasmacytoid urothelial carcinoma can be widely infiltrative and may permeate the urinary bladder in a linitis plastica-like manner and spread along the fascial planes and into the peritoneum. Compared with conventional urothelial carcinoma, PUCs have a greater chance for higher-stage disease, surgical margin positivity, and metastasis at presentation that translate into its poorer outcome. Upstaging of lamina propria-invasive (pT1) tumors diagnosed at transurethral resections is common. Because of its unfavorable behavior, a more aggressive management approach is being recommended for PUC, including consideration for upfront cystectomy in pT1 tumors. Thus, accurate distinction should be made especially on the initial transurethral resection specimens because of the therapeutic and prognostic implications. Awareness of PUC's unique clinical presentation, morphology, and immunohistochemical profile is important to avoid a potential misdiagnosis from its mimics.

摘要

浆母细胞性尿路上皮癌(PUC)是浸润性尿路上皮癌的一种变体,其特征是肿瘤细胞具有与浆细胞明显相似的形态学特征和免疫组织化学重叠,并且携带 突变。浆母细胞性尿路上皮癌可能广泛浸润,并可能以类似于皮革样胃炎的方式渗透膀胱,并沿着筋膜平面扩散并进入腹膜。与传统的尿路上皮癌相比,PUC 更有可能发生更高分期的疾病、手术切缘阳性和首发转移,从而导致其预后更差。在经尿道切除术中诊断为固有层浸润性(pT1)肿瘤的分期升级很常见。由于其不良的行为,正在为 PUC 推荐更积极的治疗方法,包括在 pT1 肿瘤中考虑 upfront 膀胱切除术。因此,由于治疗和预后的影响,特别是在初始经尿道切除标本中,应准确区分。了解 PUC 的独特临床表现、形态学和免疫组织化学特征对于避免其类似物的潜在误诊很重要。

相似文献

1
Plasmacytoid Urothelial Carcinoma: An Unusual Variant That Warrants Aggressive Management and Critical Distinction on Transurethral Resections.浆细胞性尿路上皮癌:一种需要积极管理和在经尿道切除术中仔细区分的罕见变异型。
Arch Pathol Lab Med. 2019 Dec;143(12):1562-1567. doi: 10.5858/arpa.2018-0139-RS. Epub 2019 Mar 13.
2
Plasmacytoid urothelial carcinoma with duodenal metastasis-A rare tumor with unusual site of metastasis with grim outcome.具有十二指肠转移的浆母细胞性尿路上皮癌——一种罕见的肿瘤,转移部位不常见,预后极差。
Indian J Pathol Microbiol. 2024 Jan-Mar;67(1):175-177. doi: 10.4103/ijpm.ijpm_840_21.
3
Plasmacytoid urothelial carcinoma of the urinary bladder: a case report and immunohistochemical study.膀胱浆细胞样尿路上皮癌:一例报告及免疫组织化学研究
Pathol Res Pract. 2009;205(3):189-94. doi: 10.1016/j.prp.2008.09.004. Epub 2008 Nov 28.
4
Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.再次经尿道膀胱肿瘤切除术(re-cTURBT)作为pT1期高级别(HG)疾病复发和进展的风险指标是否有用?一项单中心经验。
Arch Ital Urol Androl. 2017 Dec 31;89(4):272-276. doi: 10.4081/aiua.2017.4.272.
5
[Plasmacytoid urothelial carcinoma of the urinary bladder: a clinicopathologic study of 16 cases].[膀胱浆细胞样尿路上皮癌:16例临床病理研究]
Zhonghua Bing Li Xue Za Zhi. 2013 Jul;42(7):433-7. doi: 10.3760/cma.j.issn.0529-5807.2013.07.001.
6
Plasmacytoid urothelial carcinoma of the urinary bladder: a clinical pathological study and literature review.膀胱浆细胞样尿路上皮癌:一项临床病理研究及文献综述
Int J Clin Exp Pathol. 2012;5(6):601-8. Epub 2012 Jul 29.
7
Plasmacytoid urothelial carcinoma of the bladder.膀胱浆细胞样尿路上皮癌
Hum Pathol. 2009 Jul;40(7):1023-8. doi: 10.1016/j.humpath.2009.01.001. Epub 2009 Mar 17.
8
Plasmacytoid urothelial carcinoma: a rapid autopsy case report with unique clinicopathologic and genomic profile.浆细胞样尿路上皮癌:一例具有独特临床病理和基因组特征的快速尸检病例报告。
Diagn Pathol. 2019 Oct 21;14(1):113. doi: 10.1186/s13000-019-0896-z.
9
[Plasmacytoid urothelial carcinoma of the urinary bladder. A study of 7 cases].[膀胱浆细胞样尿路上皮癌。7例研究]
Actas Urol Esp. 2008 Sep;32(8):806-10. doi: 10.1016/s0210-4806(08)73939-1.
10
Plasmacytoid Urothelial Carcinoma of the Urinary Bladder: A Clinicopathologic and Immunohistochemical Analysis of 49 Cases.膀胱浆细胞样尿路上皮癌:49例临床病理及免疫组化分析
Am J Clin Pathol. 2017 May 1;147(5):500-506. doi: 10.1093/ajcp/aqx029.

引用本文的文献

1
Advances in Therapy for Urothelial and Non-Urothelial Subtype Histologies of Advanced Bladder Cancer: From Etiology to Current Development.晚期膀胱癌尿路上皮和非尿路上皮亚型组织学的治疗进展:从病因到当前发展
Biomedicines. 2025 Jan 1;13(1):86. doi: 10.3390/biomedicines13010086.
2
Pictorial review of multiparametric MRI in bladder urothelial carcinoma with variant histology: pearls and pitfalls.多参数 MRI 对具有异型组织学的膀胱尿路上皮癌的影像学综述:要点和陷阱。
Abdom Radiol (NY). 2024 Aug;49(8):2797-2811. doi: 10.1007/s00261-024-04397-3. Epub 2024 Jun 7.
3
Molecular characterization of plasmacytoid urothelial carcinoma and the impact on treatment implications.
浆细胞性尿路上皮癌的分子特征及其对治疗意义的影响。
Cancer Treat Res Commun. 2023;37:100779. doi: 10.1016/j.ctarc.2023.100779. Epub 2023 Nov 17.
4
Renal pelvis cancer with initial symptoms of malignant gastric outlet obstruction.以恶性胃出口梗阻为初始症状的肾盂癌。
IJU Case Rep. 2023 Oct 5;6(6):475-478. doi: 10.1002/iju5.12652. eCollection 2023 Nov.
5
Metastatic Plasmacytoid Urothelial Carcinoma Masquerading as a Primary Signet Ring Cell Carcinoma of the Duodenum.伪装成十二指肠原发性印戒细胞癌的转移性浆细胞样尿路上皮癌
Cureus. 2023 Aug 31;15(8):e44454. doi: 10.7759/cureus.44454. eCollection 2023 Aug.
6
Large, Nested Variant of Urothelial Carcinoma Is Enriched with Activating Mutations in Fibroblast Growth Factor Receptor-3 among Other Targetable Mutations.尿路上皮癌的大型嵌套变体富含成纤维细胞生长因子受体3的激活突变以及其他可靶向突变。
Cancers (Basel). 2023 Jun 13;15(12):3167. doi: 10.3390/cancers15123167.
7
Plasmacytoid Variant Urothelial Cell Carcinoma: A Case of a Histological Variant of Urinary Bladder Cancer With Aggressive Behavior.浆细胞样变异型尿路上皮癌:1例具有侵袭性生物学行为的膀胱组织学变异型癌病例
Cureus. 2023 Mar 17;15(3):e36278. doi: 10.7759/cureus.36278. eCollection 2023 Mar.
8
Plasmacytoid Urothelial Carcinoma of the Bladder That Manifests Disseminated Carcinomatosis of the Bone Marrow: A Case Report of Extremely Rapid Progression.表现为骨髓播散性癌病的膀胱浆细胞样尿路上皮癌:一例进展极快的病例报告
Case Rep Urol. 2022 Sep 15;2022:6082700. doi: 10.1155/2022/6082700. eCollection 2022.
9
Clinically undetected plasmacytoid urothelial carcinoma of the urinary bladder with non-mass-forming metastases in multiple organs: an autopsy case.临床上未被发现的膀胱浆细胞样尿路上皮癌伴多器官非肿块形成性转移:一例尸检病例
J Pathol Transl Med. 2022 Jul;56(4):217-224. doi: 10.4132/jptm.2022.03.15. Epub 2022 May 3.
10
Outcomes of poorly differentiated and plasmacytoid variant bladder urothelial carcinoma.低分化和浆细胞样变异型膀胱尿路上皮癌的预后
BJUI Compass. 2021 Aug 27;3(1):62-67. doi: 10.1002/bco2.108. eCollection 2022 Jan.